<DOC>
	<DOCNO>NCT01854463</DOCNO>
	<brief_summary>In many observational study , vitamin D deficiency relate glucose intolerance diabetes . But little randomized , control interventional study evaluate effect vitamin D type 2 diabetes . Investigators investigate effect high dose ( 2000IU ) 25-hydroxy vitamin D type 2 diabetes glycemic control , non-alcholic fatty liver disease , arterial stiffness , bone turnover marker .</brief_summary>
	<brief_title>The Effect Vitamin D Supplementation Type 2 Diabetes</brief_title>
	<detailed_description>After informed consent , investigator randomize 180 type 2 diabetes interventiona group ( 25-hydroxy vitamin 2000 IU+ elemental calcium 200mg per day ) placebo group ( elemental calcium 200mg per day ) . The participant control diabetes oral medication lifestyle intervention intervention period . Investigators exclude participant take vitamin D calcium anti-osteoporotic drug . Investigators also exclude renal insufficiency ( Cr &gt; 1.5 men Cr &gt; 1.4 woman ) heavy alcoholic . Investigators follow participant 24 week . After randomization , investigator check HbA1c , glucose , calcium , 25-hydroxyvitamin , AST , ALT , Creatinine , Parathyroid hormone , bone-specific alkaline phosphatase , serum CTX , brachial-ankle pulse wave velocity , central blood pressure , aortic augmentation index , precontrast liver compute tomography . Also investigator check body weight , height , peripheral blood pressure . At 12 week , investigator check HbA1c , 25-hydroxy vitamin D , AST , ALT , calcium , creatinine . At end study ( 24 week ) , investigator check HbA1c , glucose , AST , ALT , Creatinine , calcium , bone-specific alkaline phosphatase , serum CTX , brachial-ankle pulse wave velocity , central blood pressure , aortic augmentation index , precontrast liver compute tomography . After study complete , investiators compare data interventional group placebo group .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>TYPE 2 DIABETES MELLITUS PATIENTS WHO CONTROL GLUCOSE BY ORAL ANTIBIABETIC DRUGS OR LIFESTYLE ONLY DID NOT CHANGE ANTIDIABETIC DRUG BEFORE THE STUDY FOR 2 MONTHS normal physical activity 30 69 year &gt; =6.5 % OR &lt; 8.0 % OF HbA1c Creatinine &gt; 1.5 men , &gt; 1.4 woman heavy alcoholic take calcium vitamin antiosteoporosis drug within 3 month study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>DIABETES MELLITUS</keyword>
	<keyword>VITAMIN D</keyword>
	<keyword>ARTERIAL STIFFNESS</keyword>
	<keyword>FATTY LIVER</keyword>
	<keyword>BONE TURNOVER</keyword>
</DOC>